English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Submaximal step tests are often used for estimation of maximum oxygen consumption (VO 2max ) in humans. The validity of the Actiheart step test for VO 2max estimation was not fully studied yet. Therefore, purpose of the study was to estimate VO 2max using the Actiheart step test and to compare the data with measured VO 2max in endurance trained athletes (ATH) and healthy non-athletes (CON). 68 ATH (54% men, 28.0±5.4 yrs, 20.9±1.7 kg∙m -2 ) and 63 CON (46% men, 27.6±5.1 yrs, 22.1±1.7 kg∙m -2 ) performed the Actiheart step test and a spiroergometry for assessment of VO 2max . In addition, resting metabolic rate (RMR; indirect calorimetry), maximum heart rate (HR max ; heart rate monitoring system during spiroergometry), and sleeping heart rate (SHR; Actiheart 6-day long term measurement) were determined. Validity of two different Actiheart software entry modes was assessed: (1) AHraw (estimated RMR [Schofield] and HR max [Tanaka], SHR = 70 bpm) and (2) AHcomplete (measured RMR, HR max , and SHR). Validity was investigated using linear regression ( R 2 and standard error of the estimate (SEE)) and repeated-measures ANOVA with a Bonferroni post-hoc correction. The level of significance was set to α=0.05. VO 2max estimated by AHraw was significant related to measured VO 2max in women CON ( R 2 =0.22; p <0.05), whereas when VO 2max was estimated by AHcomplete the relation was significant in women ATH and CON, and in men CON ( R 2 =0.17-0.24; p <0.05). AHraw significantly underestimated VO 2max in the total sample by 8% (51.4±10.2 vs. 55.9±7.6 ml∙kg -1 ∙min -1 ; p <0.0001), whereas no significant difference between AHcomplete and the criterion method was found (57.0±11.1 vs. 55.9±7.6 ml∙kg -1 ∙min -1 ; p =0.26 ). The Actiheart step test is an acceptable tool for the estimation of VO 2max if an error within 8% can be tolerated. However, accuracy of the VO 2max prediction is much improved when entering measured variables, such as RMR, SHR, and HR max , into the software.

Validity of the Actiheart step test for the estimation of maximum oxygen consumption in endurance athletes and healthy controls